TAK-441

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-441, covering 2013-07-02 to 2013-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies [Phase 1]